Likewise using the 3 × Tg AD mouse model, Liang et al. reported that berberine was able to suppress the PERK-eIF2α-BACE1 signaling pathway (a key pathway in Aβ production), thereby reducing the production and deposition of Aβ peptides and mitigating cell death [115]. Here, BACE1 is linked to Alzheimer disease.